{"id":2,"date":"2025-09-12T16:13:30","date_gmt":"2025-09-12T07:13:30","guid":{"rendered":"https:\/\/www.mdrex.co.jp\/?page_id=2"},"modified":"2025-10-08T11:07:58","modified_gmt":"2025-10-08T02:07:58","slug":"expansion","status":"publish","type":"page","link":"https:\/\/www.mdrex.co.jp\/en\/expansion\/","title":{"rendered":"Procedures for Entering the Japanese Market for Medical Devices"},"content":{"rendered":"<div class=\"tcdce-body\"><div class=\"p-sc-design1\"><div class=\"p-sc-design1-item\"><div class=\"p-sc-design1-item-image\"><img loading=\"lazy\" decoding=\"async\" width=\"200\" height=\"160\" src=\"https:\/\/www.mdrex.co.jp\/wp-content\/uploads\/2025\/09\/Pictogram_Expansion_200x160_11.png\" class=\"p-sc-layout-cover\" alt=\"\" \/><\/div><div class=\"p-sc-design1-item-content\"><div class=\"p-sc-design1-item-content-title\">Formulation of Market Entry Strategies<\/div><div class=\"p-sc-design1-item-content-desc\">\u2022 Design customized market entry strategies considering product characteristics and the Japanese healthcare environment<br \/>\r\n\u2022 Support determination of medical device applicability through the Ministry of Health, Labour and Welfare and PMDA<br \/>\r\n\u2022 Class classification and equivalent product investigation via JMDN<br \/>\r\n\u2022 Develop a roadmap through market analysis, competitor assessment, and insurance system evaluation<br \/>\r\n\u2022 Conduct KOL surveys in Japan and provide introductions<\/div><\/div><\/div><div class=\"p-sc-design1-item\"><div class=\"p-sc-design1-item-image\"><img loading=\"lazy\" decoding=\"async\" width=\"200\" height=\"160\" src=\"https:\/\/www.mdrex.co.jp\/wp-content\/uploads\/2025\/09\/Pictogram_Expansion_200x160_21.png\" class=\"p-sc-layout-cover\" alt=\"\" \/><\/div><div class=\"p-sc-design1-item-content\"><div class=\"p-sc-design1-item-content-title\">Implementation of PMDA Pre-Consultation<\/div><div class=\"p-sc-design1-item-content-desc\">\u2022 Utilize consultation systems such as SaMD unified consultation, general consultation, pre-development consultation, and clinical trial necessity consultation to coordinate with regulatory authorities on product class, generic name, and the need for clinical trials <br \/>\r\n\u2022 Support strategy formulation and preparation of materials for PMDA pre-consultation<br \/>\r\n- In Japan, such pre-consultations are extremely important. Therefore, it is essential to provide the regulatory authorities with a thorough explanation of the product and obtain the necessary feedback, even if the process takes time.<\/div><\/div><\/div><div class=\"p-sc-design1-item\"><div class=\"p-sc-design1-item-image\"><img loading=\"lazy\" decoding=\"async\" width=\"200\" height=\"160\" src=\"https:\/\/www.mdrex.co.jp\/wp-content\/uploads\/2025\/09\/Pictogram_Expansion_200x160_31.png\" class=\"p-sc-layout-cover\" alt=\"\" \/><\/div><div class=\"p-sc-design1-item-content\"><div class=\"p-sc-design1-item-content-title\">Applications for Approval\/Certification<\/div><div class=\"p-sc-design1-item-content-desc\">\u2022 Respond to PMDA safety and efficacy reviews as well as manufacturing site quality management (JGMP) inspections<br \/>\r\n\u2022 Review compliance with GCP for submitted clinical trial data<br \/>\r\n\u2022 Classify products based on equivalence to already approved devices<br \/>\r\n\u3000- New Medical Device: A device with new intended use, effect, operating principle, or performance; submission of clinical trial data is mandatory <br \/>\r\n\u3000- Modified Medical Device: A device with improved performance or effects compared to existing products; clinical evaluation of the modified features is required<br \/>\r\n\u3000- Generic Medical Device: A device substantially equivalent to an existing product; simplified procedures can be applied<\/div><\/div><\/div><div class=\"p-sc-design1-item\"><div class=\"p-sc-design1-item-image\"><img loading=\"lazy\" decoding=\"async\" width=\"200\" height=\"160\" src=\"https:\/\/www.mdrex.co.jp\/wp-content\/uploads\/2025\/09\/Pictogram_Expansion_200x160_41.png\" class=\"p-sc-layout-cover\" alt=\"\" \/><\/div><div class=\"p-sc-design1-item-content\"><div class=\"p-sc-design1-item-content-title\">Insurance Listing Applications and Strategy Development<\/div><div class=\"p-sc-design1-item-content-desc\">\u2022 Based on Japan\u2019s prohibition of mixed medical practice, insurance listing strategy is critical for successful market entry.<br \/>\r\n\u3000- For products classified as A (comprehensive) or B, existing medical fees are applied. <br \/>\r\n\u2022 Support for C1\/C2 listing strategies, cost-effectiveness analysis, and insurance price determination<br \/>\r\n\u2022 Assistance with consultations with the Ministry of Health, Labour and Welfare and securing economic and clinical evidence<br \/>\r\n\u2022 Support for obtaining and submitting KOL opinion letters within Japan<\/div><\/div><\/div><div class=\"p-sc-design1-item\"><div class=\"p-sc-design1-item-image\"><img loading=\"lazy\" decoding=\"async\" width=\"200\" height=\"160\" src=\"https:\/\/www.mdrex.co.jp\/wp-content\/uploads\/2025\/09\/Pictogram_Expansion_200x160_51.png\" class=\"p-sc-layout-cover\" alt=\"\" \/><\/div><div class=\"p-sc-design1-item-content\"><div class=\"p-sc-design1-item-content-title\">Domestic Sales \/ Distribution in Japan<\/div><div class=\"p-sc-design1-item-content-desc\">\u2022 Support for introducing distributors and building a distribution network based on insurance claim volumes, medical institution channels, and economic analysis<br \/>\r\n\u2022 Execution of local marketing and sales strategies in collaboration with Japanese partner companies<\/div><\/div><\/div><\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":75,"parent":0,"menu_order":1000,"comment_status":"closed","ping_status":"open","template":"page__lp.php","meta":{"footnotes":""},"class_list":["post-2","page","type-page","status-publish","has-post-thumbnail","hentry"],"aioseo_notices":[],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.mdrex.co.jp\/en\/wp-json\/wp\/v2\/pages\/2","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.mdrex.co.jp\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.mdrex.co.jp\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.mdrex.co.jp\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.mdrex.co.jp\/en\/wp-json\/wp\/v2\/comments?post=2"}],"version-history":[{"count":3,"href":"https:\/\/www.mdrex.co.jp\/en\/wp-json\/wp\/v2\/pages\/2\/revisions"}],"predecessor-version":[{"id":64,"href":"https:\/\/www.mdrex.co.jp\/en\/wp-json\/wp\/v2\/pages\/2\/revisions\/64"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.mdrex.co.jp\/en\/wp-json\/wp\/v2\/media\/75"}],"wp:attachment":[{"href":"https:\/\/www.mdrex.co.jp\/en\/wp-json\/wp\/v2\/media?parent=2"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}